Erratum: Prevention of progressive joint destruction in adjuvant induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR217840 (European Journal of Pharmacology (2005) 508 (239-247) PII: S0014-2999(04)01396- 2 and DOI: 10.1016/j.ejphar.2004.12.014);Prevention of progressive joint destruction in adjuvant induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR217840

European Journal of Pharmacology

Volumn 508, Issue 1-3, 2005, Pages 239-247

  Ishikawa, Takeshi ^a   Nishigaki, Fusako ^a   Miyata, Susumu ^a   Hirayama, Yoshitaka ^a   Minoura, Kyoko ^a   Imanishi, Junko ^a   Neya, Masahiro ^a   Mizutani, Tsuyoshi ^a   Imamura, Yoshimasa ^a   Ohkubo, Yoshitaka ^a   Mutoh, Seitaro ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Arthritis, adjyuvant induced; Bone destruction; Matrix metalloproteinase; Osteoclast

Indexed keywords

1 [[5 (4 FLUOROPHENYL) 2 THIENYL]SULFONYL] N HYDROXY 4 (METHYLSULFONYL) 2 PIPERAZINECARBOXAMIDE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; FR 217840; MATRIX METALLOPROTEINASE INHIBITOR; PYRIDINOLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTHRITIS; ARTICLE; CELL COUNT; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; INFLAMMATION; JOINT DESTRUCTION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; RAT STRAIN;

EID: 19944433440     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.04.001     Document Type: Erratum

References (38)

1. L. Blavier, and J.M. Delaisse Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones J. Cell. Sci. 108 1995 3649 3659
2. B. Bolon, S. Morony, Y. Cheng, Y.L. Hu, and U. Feige Osteoclast numbers in Lewis rats with adjuvant-induced arthritis: identification of preferred sites and parameters for rapid quantitative analysis Vet. Pathol. 41 2004 30 36
3. S. Bord, A. Horner, R.M. Hembry, J.J. Reynolds, and J.E. Compston Production of collagenase by human osteoblasts and osteoclasts in vivo Bone 19 1996 35 40
4. T.J. Chambers, J.A. Darby, and K. Fuller Mammalian collagenase predisposes bone surfaces to osteoclastic resorption Cell Tissue Res. 241 1985 671 675
5. R. Chiusaroli, A. Maier, M.C. Knight, M. Byrne, L.M. Calvi, R. Baron, S.M. Krane, and E. Schipani Collagenase cleavage of type I collagen is essential for both basal and parathyroid hormone (PTH)/PTH-related peptide receptor-induced osteoclast activation and has differential effects on discrete bone compartments Endocrinology 144 2003 4106 4116
6. J.G. Conway, J.A. Wakefield, R.H. Brown, B.E. Marron, L. Sekut, S.A. Stimpson, A. McElroy, J.A. Menius, J.J. Jeffreys, and R.L. Clark Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor J. Exp. Med. 182 1995 449 457
7. J.M. Delaisse, Y. Eeckhout, L. Neff, C. Francois-Gillet, P. Henriet, Y. Su, G. Vaes, and R. Baron (Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment J. Cell. Sci. 106 1993 1071 1082
8. J.M. Delaisse, T.L. Andersen, M.T. Engsig, K. Henriksen, T. Troen, and L. Blavier Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities Microsc. Res. Tech. 61 2003 504 513
9. G. Dew, G. Murphy, H. Stanton, R. Vallon, P. Angel, J.J. Reynolds, and R.M. Hembry Localisation of matrix metalloproteinases and TIMP-2 in resorbing mouse bone Cell Tissue Res. 299 2000 385 394
10. M.T. Engsig, Q.J. Chen, T.H. Vu, A.C. Pedersen, B. Therkidsen, L.R. Lund, K. Henriksen, T. Lenhard, N.T. Foged, Z. Werb, and J.M. Delaisse Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones J. Cell Biol. 151 2000 879 889
11. V. Everts, W. Korper, D.C. Jansen, J. Steinfort, I. Lammerse, S. Heera, A.J. Docherty, and W. Beertsen Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone FASEB J. 13 1999 1219 1230
12. M. Feldmann, F.M. Brennan, and R.N. Maini Rheumatoid arthritis Cell 85 1996 307 310
13. T. Goto, H. Maeda, and T. Tanaka A selective inhibitor of matrix metalloproteinases inhibits the migration of isolated osteoclasts by increasing the life span of podosomes J. Bone Miner. Metab. 20 2002 98 105
14. M. Hakala, L. Risteli, J. Manelius, P. Nieminen, and J. Risteli Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis Ann. Rheum. Dis. 52 1993 866 869
15. T. Hamada, N. Arima, M. Shindo, K. Sugama, and Y. Sasaguri Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase-inhibitor Br. J. Pharmacol. 131 2000 1513 1520
16. R. Hashida, M. Kuwada, K.I. Chiba, T. Horizoe, H. Shirota, and Y. Nagai A factor derived from polymorphonuclear leukocytes enhances interleukin-1-induced synovial cell collagenase and prostaglandin E2 production in rats Eur. J. Biochem. 236 1996 517 522
17. L.S. Holliday, H.G. Welgus, C.J. Fliszar, G.M. Veith, J.J. Jeffrey, and S.L. Gluck Initiation of osteoclast bone resorption by interstitial collagenase J. Biol. Chem. 272 1997 22053 22058
18. P. Hou, T. Troen, M.C. Ovejero, T. Kirkegaard, T.L. Andersen, I. Byrjalsen, M. Ferreras, T. Sato, S.D. Shapiro, N.T. Foged, and J.M. Delaisse Matrix metalloproteinase-12 (MMP-12) in osteoclasts: new lesson on the involvement of MMPs in bone resorption Bone 34 2004 37 47
19. C. Jackson, M. Nguyen, J. Arkell, and P. Sambrook Selective matrix metalloproteinase (MMP) inhibition in rheumatoid arthritis-targetting gelatinase A activation Inflamm. Res. 50 2001 183 186
20. B. Joe, and R.L. Wilder Animal models of rheumatoid arthritis Mol. Med. Today 5 1999 367 369
21. K. Kobayashi, N. Takahashi, E. Jimi, N. Udagawa, M. Takami, S. Kotake, N. Nakagawa, M. Kinosaki, K. Yamaguchi, N. Shima, H. Yasuda, T. Morinaga, K. Higashio, T.J. Martin, and T. Suda Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction J. Exp. Med. 191 2000 275 286
22. H. Kroger, I. Arnala, V. Rehnberg, M. Hamalainen, and E. Alhava Histomorphometry of periarticular bone in rheumatoid arthritis Ann. Chir. Gynaecol. 83 1994 56 62
23. E.J. Lewis, J. Bishop, K.M. Bottomley, D. Bradshaw, M. Brewster, M.J. Broadhurst, P.A. Brown, J.M. Budd, L. Elliott, A.K. Greenham, W.H. Johnson, J.S. Nixon, F. Rose, B. Sutton, and K. Wilson Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo Br. J. Pharmacol. 121 1997 540 546
24. J. McComb, T. Gould, E. Chlipala, G. Sennelo, J. Frazier, G. Kieft, J. Seely, C.K. Edwards III, and A. Bendele Antiarthritic activity of soluble tumor necrosis factor receptor type I forms in adjuvant arthritis: correlation of plasma levels with efficacy J. Rheumatol. 26 1999 1347 1351
25. M.R. Michaelides, and M.L. Curtin Recent advances in matrix metalloproteinase inhibitors research Curr. Pharm. Des. 5 1999 787 819
26. J.A. Miller, R.Q. Liu, G.L. Davis, M.A. Pratta, J.M. Trzaskos, and R.A. Copeland A microplate assay specific for the enzyme aggrecanase Anal. Biochem. 314 2003 260 265
27. Y. Okada, K. Naka, K. Kawamura, T. Matsumoto, I. Nakanishi, N. Fujimoto, H. Sato, and M. Seiki Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase=gelatinase B) in osteoclasts: implications for bone resorption Lab. Invest. 72 1995 311 322
28. P. Reponen, C. Sahlberg, C. Munaut, I. Thesleff, and K. Tryggvason High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development J. Cell Biol. 124 1994 1091 1102
29. M.L. Sassi, S. Aman, M. Hakala, R. Luukkainen, and J. Risteli Assay for cross-linked carboxyterminal telopeptide of type I collagen (ICTP) unlike CrossLaps assay reflects increased pathological degradation of type I collagen in rheumatoid arthritis Clin. Chem. Lab. Med. 41 2003 1038 1044
30. T. Sato, M. del Carmen Ovejero, P. Hou, A.M. Heegaard, M. Kumegawa, N.T. Foged, and J.M. Delaisse Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts J. Cell. Sci. 110 1997 589 596
31. T. Sato, N.T. Foged, and J.M. Delaisse The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors J. Bone Miner. Res. 13 1998 59 66
32. S. Shimizu, S. Shiozawa, K. Shiozawa, S. Imura, and T. Fujita Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis Arthritis Rheum. 28 1985 25 31
33. T. Suda, N. Takahashi, and T.J. Martin Modulation of osteoclast differentiation Endocr. Rev. 13 1992 66 80
34. K. Tezuka, K. Nemoto, Y. Tezuka, T. Sato, Y. Ikeda, M. Kobori, H. Kawashima, H. Eguchi, Y. Hakeda, and M. Kumegawa Identification of matrix metalloproteinase 9 in rabbit osteoclasts J. Biol. Chem. 269 1994 15006 15009
35. N. Udagawa, S. Kotake, N. Kamatani, N. Takahashi, and T. Suda The molecular mechanism of osteoclastogenesis in rheumatoid arthritis Arthritis Res. 4 2002 281 289
36. G. Vaes, J.M. Delaisse, and Y. Eeckhout Relative roles of collagenase and lysosomal cysteine-proteinases in bone resorption Matrix, Suppl. 1 1992 383 388
37. A.L. Wucherpfennig, Y.P. Li, W.G. Stetler-Stevenson, A.E. Rosenberg, and P. Stashenko Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts J. Bone Miner. Res. 9 1994 549 556
38. W. Zhao, M.H. Byrne, B.F. Boyce, and S.M. Krane Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice J. Clin. Invest. 103 1999 517 524